Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends
NCT ID: NCT07013864
Last Updated: 2025-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
28 participants
OBSERVATIONAL
2024-07-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antibiotic Stewardship to Prevent Early Sepsis in Preterm Infants
NCT06930911
Multi-resistant and Spore-forming Bacteria in a Neonatal Intensive Care Unit
NCT06391463
Linezolid-resistant Staphylococcus Epidermidis in ICU and Risk Factors Analysis
NCT03140410
Epidemiology and Genomic Surveillance of Staphylococcus Aureus in ICU Neonatology
NCT06267352
Bacillus Cereus Invasive Infections in Preterm Neonates Hospitalized in French Hospitals
NCT06973174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalized in the Neonatal and Neonatal Resuscitation department of the Saint-Denis
* At least one isolation of S. haemolyticus in blood cultures or catheter cultures
2 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier de Saint-Denis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
France
Saint-Denis, France, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0086_NEONATOLOGIE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.